EBV-SPECIFIC MICRO-RNA VIA EXOSOME: A KEY INTER-CELLULAR MACHINERY BETWEEN EBV+ TUMOUR AND TUMOUR-SURROUNDING IMMUNE CELLS?

166

  • Kotani, A.
  • Yokoyama, K.
  • Lu, J.
  • Yahata, T.
  • Ando, K.
  • Imadome, K.
  • Nakamura, N.

  • 1Institute of Innovative Science and Technology, Tokai University, Isehara, Japan;

    2Immunology, Tokai University School of Medicine, Isehara, Japan;

    3Hematology, Tokai University School of Medicine, Isehara, Japan;

    4Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan;

    5Infectious Diseases, National Research Institute for Child Health and Development, Tokyo, Japan;

    6Pathology, Tokai University School of Medicine, Isehara, Japan.

Hematological Oncology 31:p 152, June 2013.
Copyright © 2013 John Wiley & Sons, Inc.